Evaluation of good clinical response to neoadjuvant chemotherapy in primary breast cancer using [ 18 F]-fluorodeoxyglucose positron emission tomography

By Burcombe R.J.   Makris A.   Pittam M.   Lowe J.   Emmott J.   Wong W.L.  

European Journal of Cancer, Vol. 38, Iss. 3, 2002-01 ,pp. : 375-379

Elsevier

Access to resources Recommend Favorite

Positron Emission Tomography (PET) and Mammography (PEM) for Breast Cancer: Importance to Surgeons

By Tafra Lorraine  

Annals of Surgical Oncology, Vol. 14, Iss. 1, 2007-01 ,pp. : 3-13

Springer Publishing Company

Access to resources Recommend Favorite

Determinants of Response to Neoadjuvant Chemotherapy for Esophageal Cancer Using ¹⁸F-fluorodeoxiglucose Positron Emission Tomography (¹⁸F-FDG-PET)

By Miyata Hiroshi   Yamasaki Makoto   Takahashi Tsuyoshi   Murakami Kohei   Tanaka Koji   Yukinori Kurokawa   Nakajima Kiyokazu   Takiguchi Shuji   Morii Eiichi   Hatazawa Jun   Mori Masaki   Doki Yuichiro  

Annals of Surgical Oncology, Vol. 21, Iss. 2, 2014-02 ,pp. : 575-582

Springer Publishing Company

Access to resources Recommend Favorite

Prospective multicenter study of axillary nodal staging by positron emission tomography in breast cancer: a report of the staging of breast cancer with PET study group

By  

The Women's Oncology Review, Vol. 4, Iss. 2, 2004-06 ,pp. : 161-162

Informa Healthcare

Access to resources Recommend Favorite

Can Positron Emission Tomography (PET) be Used to Detect Subclinical Response to Cancer Therapy?

By Price P.   Jones T.  

European Journal of Cancer, Vol. 31, Iss. 12, 1995-11 ,pp. : 1924-1927

Elsevier

Access to resources Recommend Favorite